Data / Drug companies / Srini Pharmaceuticals Private Limited
Srini Pharmaceuticals Private Limited: 16 products in the FDA NDC directory, labeler code 66174
Updated November 6, 2026. Source: US Food and Drug Administration, National Drug Code Directory (openFDA).
Srini Pharmaceuticals Private Limited (labeler code 66174) lists 16 products in the FDA National Drug Code Directory. By type: 16 bulk ingredients. Its main marketing category is bulk ingredients. The newest product started marketing on December 21, 2021.
The request: Watch Srini Pharmaceuticals Private Limited (FDA labeler code 66174): each new product listing and each discontinued product. $10 of work on sign-up, no card.
SpecStream is the live web data engine for teams and agents. It reads the National Drug Code Directory that FDA publishes, and this page is that reading. Ask for the companies that make a drug, a class or a dosage form, with their headquarters, website and size added from the web, and new listings and discontinued products arrive in your sheet, CRM, Slack or agent as FDA posts them.
- Labeler code
- 66174
- Products in commercial distribution
- 16
- Packages
- 16
- Finished drugs by generic name
- 0
- Prescription products
- 0
- Over the counter products
- 0
- Controlled substance products
- Schedule V 1
- Started marketing in the last 12 months
- 0
- Earliest marketing start
- December 6, 2012
- openFDA record search
- api.fda.gov
Products by marketing category
Share of the company's products in commercial distribution.
| Marketing category | Products | Share |
|---|---|---|
| Bulk ingredients | 16 | 100% |
Products by type
| Type | Products | Share |
|---|---|---|
| Bulk ingredients | 16 | 100% |
Dosage forms
| Dosage form | Products | Share |
|---|---|---|
| Powder | 16 | 100% |
Newest products
By marketing start date.
| Product | Product NDC | Dosage form | Marketing category | Marketing start |
|---|---|---|---|---|
| Pregabalin | 66174-0031 | Powder | Bulk ingredients | December 21, 2021 |
| Apixaban | 66174-0091 | Powder | Bulk ingredients | November 23, 2021 |
| Dabigatran etexilate mesylate | 66174-0090 | Powder | Bulk ingredients | November 23, 2021 |
| Rivaroxaban | 66174-0087 | Powder | Bulk ingredients | November 22, 2021 |
| Levetiracetam | 66174-0044 | Powder | Bulk ingredients | January 29, 2020 |
| Esomeprazole magnesium trihydrate | 66174-0084 | Powder | Bulk ingredients | January 11, 2020 |
| Amlodipine besylate | 66174-0020 | Powder | Bulk ingredients | May 24, 2019 |
| Labetalol hydrochloride | 66174-0003 | Powder | Bulk ingredients | February 27, 2019 |
| Dextromethorphan hydrobromide | 66174-0085 | Powder | Bulk ingredients | August 7, 2017 |
| Omeprazole magnesium | 66174-0072 | Powder | Bulk ingredients | May 21, 2015 |
| Tadalafil | 66174-0021 | Powder | Bulk ingredients | March 24, 2015 |
| Raloxifene hydrochloride | 66174-0077 | Powder | Bulk ingredients | February 23, 2015 |
| Enalapril maleate | 66174-0074 | Powder | Bulk ingredients | February 23, 2015 |
| Pantoprazole sodium sesquihydrate | 66174-0038 | Powder | Bulk ingredients | February 4, 2014 |
| Omeprazole | 66174-0013 | Powder | Bulk ingredients | May 22, 2013 |
| Levofloxacin hemihydrate | 66174-0018 | Powder | Bulk ingredients | December 6, 2012 |
CC0 1.0 public domain dedication (openFDA). Counts are products in the FDA National Drug Code Directory on November 6, 2026: 138,262 products in commercial distribution, meaning without a marketing end date in the past. A company is a labeler code; one company can hold several codes, and the directory carries no address. Inclusion in the directory is not FDA approval, and the marketing category says under which kind of application or rule a product is sold. This page uses openFDA data and is not endorsed or certified by FDA. Free to reuse with credit to SpecStream under CC BY 4.0. Spot a wrong value? Write to [email protected] with the link to this page.